US5702359A
(en)
*
|
1995-06-06 |
1997-12-30 |
Genetronics, Inc. |
Needle electrodes for mediated delivery of drugs and genes
|
US5993434A
(en)
*
|
1993-04-01 |
1999-11-30 |
Genetronics, Inc. |
Method of treatment using electroporation mediated delivery of drugs and genes
|
US6261281B1
(en)
*
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
EP0991426B2
(fr)
|
1997-06-30 |
2007-03-28 |
Institut Gustave Roussy |
Procede de transfert d'acide nucleique dans le muscle strie
|
DE69829287T2
(de)
*
|
1997-06-30 |
2006-04-13 |
Centre National De La Recherche Scientifique (Cnrs) |
Verbesserung der verabreichung der nukleinsäure in zellen der plurizellulären eukaryotischen organismen und kombination zur durchführung des verfahrens
|
US6241701B1
(en)
|
1997-08-01 |
2001-06-05 |
Genetronics, Inc. |
Apparatus for electroporation mediated delivery of drugs and genes
|
US6055453A
(en)
|
1997-08-01 |
2000-04-25 |
Genetronics, Inc. |
Apparatus for addressing needle array electrodes for electroporation therapy
|
US20040229363A1
(en)
*
|
1998-06-24 |
2004-11-18 |
Ed Nolan |
High efficiency transfection based on low electric field strength, long pulse length
|
JP2003505114A
(ja)
|
1998-07-13 |
2003-02-12 |
ジェネトロニクス、インコーポレーテッド |
パルス電場による皮膚および筋肉を標的とした遺伝子治療
|
US7922709B2
(en)
|
1998-07-13 |
2011-04-12 |
Genetronics, Inc. |
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
US6678556B1
(en)
*
|
1998-07-13 |
2004-01-13 |
Genetronics, Inc. |
Electrical field therapy with reduced histopathological change in muscle
|
EP1148885A4
(fr)
*
|
1999-02-08 |
2002-05-08 |
Chiron Corp |
Augmentation electriquement induite de l'immunite et de l'efficacite de vaccins d'adn in vivo
|
US6593130B1
(en)
|
1999-04-16 |
2003-07-15 |
The Regents Of The University Of California |
Method and apparatus for ex vivo and in vivo cellular electroporation of gene protein or drug therapy
|
CA2401239A1
(fr)
*
|
2000-03-03 |
2001-09-13 |
Valentis, Inc. |
Compositions ameliorees de poloxamere et de poloxamine generatrices d'acide nucleique
|
JP2004532654A
(ja)
|
2000-05-22 |
2004-10-28 |
マーク・アンド・カンパニー・インコーポレイテッド |
薬剤投与システム性能評価システム及び方法
|
US6733485B1
(en)
|
2001-05-25 |
2004-05-11 |
Advanced Bionics Corporation |
Microstimulator-based electrochemotherapy methods and systems
|
US20040204669A1
(en)
*
|
2001-07-05 |
2004-10-14 |
Hofmann Gunter A. |
Apparatus for electroporation mediated delivery for drugs and genes
|
US7713740B2
(en)
*
|
2001-08-24 |
2010-05-11 |
University Of South Florida |
Method of using electric fields to facilitate the entry of molecules into cells in vivo
|
ATE467680T1
(de)
|
2001-10-11 |
2010-05-15 |
Merck Sharp & Dohme |
Hepatitis-c-virus-impfstoff
|
CN1880457B
(zh)
|
2001-10-11 |
2010-05-26 |
麦克公司 |
Ad6重组核酸
|
CN1612691A
(zh)
*
|
2001-11-08 |
2005-05-04 |
加利福尼亚大学董事会 |
纠正心脏传导障碍的方法和组合物
|
AU2002360648B2
(en)
*
|
2001-12-14 |
2009-01-08 |
Genetronics, Inc. |
Methods for particle-assisted polynucleotide immunization using a pulsed electric field
|
JP2005527490A
(ja)
*
|
2002-01-18 |
2005-09-15 |
イノヴィオ アーエス |
筋肉内投与のための二重特異性抗体dna構築物
|
US8209006B2
(en)
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
US7245963B2
(en)
*
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
EP1480692A2
(fr)
|
2002-03-07 |
2004-12-01 |
Merck & Co., Inc. |
Seringue clinique avec des aspects de stimulation electrique
|
US6912417B1
(en)
*
|
2002-04-05 |
2005-06-28 |
Ichor Medical Systmes, Inc. |
Method and apparatus for delivery of therapeutic agents
|
AU2003223351A1
(en)
|
2002-04-16 |
2003-11-03 |
Cyto Pulse Sciences, Inc. |
Method of treating biological materials with translating electrical fields and electrode polarity reversal
|
US20040106896A1
(en)
*
|
2002-11-29 |
2004-06-03 |
The Regents Of The University Of California |
System and method for forming a non-ablative cardiac conduction block
|
US7328064B2
(en)
|
2002-07-04 |
2008-02-05 |
Inovio As |
Electroporation device and injection apparatus
|
SG136133A1
(en)
|
2004-03-08 |
2007-10-29 |
Ichor Medical Systems Inc Ca U |
Improved apparatus for electrically mediated delivery of therapeutic agents
|
TW200613554A
(en)
|
2004-06-17 |
2006-05-01 |
Wyeth Corp |
Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
|
JP2008532560A
(ja)
|
2005-03-19 |
2008-08-21 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
微弱電界ネットワークを仲介して行う、生体外で細胞内に遺伝子、タンパク質および薬剤を送達する方法および装置
|
JP5475279B2
(ja)
|
2005-06-17 |
2014-04-16 |
イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ |
C型肝炎ウイルス核酸ワクチン
|
US20070190032A1
(en)
*
|
2006-02-13 |
2007-08-16 |
Oncolytics Biotech Inc. |
Use of Local Immune Suppression to Enhance Oncolytic Viral Therapy
|
CA2668649A1
(fr)
|
2006-11-17 |
2008-05-29 |
Genetronics, Inc. |
Methodes accroissant la reponse immunitaire par vaccination assistee par electroporation, et renfort
|
CN101998965B
(zh)
|
2007-11-01 |
2014-03-12 |
安斯泰来制药有限公司 |
免疫抑制性多肽与核酸
|
JP5744719B2
(ja)
*
|
2008-04-04 |
2015-07-08 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
チクングニヤウィルスタンパク質の共通配列、これをコードする核酸分子、並びにこれを使用する組成物および方法
|
JP5873717B2
(ja)
*
|
2008-04-04 |
2016-03-01 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
Il−28及び組成物を用いたワクチン及び免疫治療薬並びにその使用方法
|
EP2147697A1
(fr)
|
2008-07-21 |
2010-01-27 |
Centre National De La Recherche Scientifique-CNRS |
Procédé et dispositif pour appliquer des champs électriques dans un matériau conducteur
|
EP2156860A1
(fr)
|
2008-08-20 |
2010-02-24 |
Centre National De La Recherche Scientifique-CNRS |
Procédé de fabrication d'électrodes isolées pour l'application de champs électriques dans un matériau conducteur
|
US8207138B2
(en)
|
2009-05-19 |
2012-06-26 |
Medtronic, Inc. |
Methods and devices for improved efficiency of RNA delivery to cells
|
US20100298697A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Medtronic, Inc. |
Method and devices for improved efficiency of rna delivery to cells
|
CN102821790A
(zh)
|
2009-09-14 |
2012-12-12 |
宾夕法尼亚大学托管会 |
包含IL-15受体α和/或编码IL-15受体α的核酸分子的疫苗和免疫治疗剂,以及其使用方法
|
KR20210149203A
(ko)
|
2009-11-02 |
2021-12-08 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
구제역 바이러스(fmdv) 공통 단백질, 이를 위한 코딩 서열 및 이로부터 만들어진 백신
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
CN102781952B
(zh)
|
2010-02-08 |
2015-09-02 |
宾夕法尼亚大学托管会 |
编码rantes的核酸分子、包含其的组合物以及其使用方法
|
AU2011312465B2
(en)
|
2010-09-27 |
2015-07-23 |
Inovio Pharmaceuticals, Inc |
Consensus antigen constructs and vaccines made therefrom, and methods of using same to treat malaria
|
MX346784B
(es)
|
2010-11-12 |
2017-03-31 |
Inovio Pharmaceuticals Inc |
Antigenos prostaticos de consenso, molecula de acido nucleico que los codifica y vacuna y usos que los comprenden.
|
EP2670443A4
(fr)
|
2011-01-31 |
2015-10-14 |
Univ Pennsylvania |
Molécules d'acide nucléique codant de nouveaux antigènes d'herpès, vaccin les comprenant et procédés pour les utiliser
|
PT2672992T
(pt)
|
2011-02-11 |
2020-07-27 |
Univ Pennsylvania |
Molécula de ácidos nucleicos codificando proteína nuclear do vírus da hepatite b e vacina compreendendo a mesma
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
US9457183B2
(en)
|
2011-06-15 |
2016-10-04 |
Tripep Ab |
Injection needle and device
|
CA2841852C
(fr)
|
2011-07-11 |
2020-06-30 |
Inovio Pharmaceuticals, Inc. |
Vaccins fournissant une protection croisee contre les arenavirus et leur procede d'utilisation
|
JP6407028B2
(ja)
|
2011-12-12 |
2018-10-17 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
MRSAのPBP2a及びその断片を含むタンパク質、それをコードする核酸、並びにMRSA感染を予防する及び治療するための組成物及びそれらの使用
|
US9272024B2
(en)
|
2011-12-12 |
2016-03-01 |
The Trustees Of The University Of Pennsylvania |
Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
|
EP2836505B1
(fr)
|
2012-04-10 |
2019-01-23 |
The Trustees Of The University Of Pennsylvania |
Antigènes consensus du virus syncytial respiratoire humain, constructions d'acide nucléique et vaccins préparés à partir de celles-ci, et leurs procédés d'utilisation
|
KR20240010758A
(ko)
|
2012-04-12 |
2024-01-24 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
필로바이러스 공통 항원, 이로부터 제조된 핵산 구조체 및 백신, 및 이를 사용하는 방법
|
DE102012013534B3
(de)
|
2012-07-05 |
2013-09-19 |
Tobias Sokolowski |
Vorrichtung für repetitive Nervenstimulation zum Abbau von Fettgewebe mittels induktiver Magnetfelder
|
WO2014064534A2
(fr)
|
2012-10-05 |
2014-05-01 |
Chrontech Pharma Ab |
Aiguille d'injection, dispositif, compositions immunogènes et procédé d'utilisation
|
SI2931304T1
(sl)
|
2012-12-13 |
2021-11-30 |
The Trustees Of The University Of Pennsylvania |
Cepivo proti WT1
|
KR20230062674A
(ko)
|
2013-03-15 |
2023-05-09 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
암 백신 및 이를 이용한 치료 방법
|
BR112015022582B1
(pt)
|
2013-03-15 |
2024-01-09 |
The Trustees Of The University Of Pennsylvania |
Molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo
|
WO2015017734A1
(fr)
|
2013-07-31 |
2015-02-05 |
Board Of Trustees Of The University Of Arkansas |
Compositions et méthodes permettant de traiter et de prévenir le cancer par ciblage des antigènes glucidiques associés à la tumeur
|
CN105829341A
(zh)
|
2013-12-13 |
2016-08-03 |
宾夕法尼亚大学理事会 |
Dna抗体构建体及其使用方法
|
CA2969214A1
(fr)
|
2014-12-01 |
2016-06-09 |
The Trustees Of The University Of Pennsylvania |
Constructions d'anticorps d'adn et leur procede d'utilisation
|
US11491342B2
(en)
|
2015-07-01 |
2022-11-08 |
Btl Medical Solutions A.S. |
Magnetic stimulation methods and devices for therapeutic treatments
|
US10695575B1
(en)
|
2016-05-10 |
2020-06-30 |
Btl Medical Technologies S.R.O. |
Aesthetic method of biological structure treatment by magnetic field
|
US20180001107A1
(en)
|
2016-07-01 |
2018-01-04 |
Btl Holdings Limited |
Aesthetic method of biological structure treatment by magnetic field
|
US11266850B2
(en)
|
2015-07-01 |
2022-03-08 |
Btl Healthcare Technologies A.S. |
High power time varying magnetic field therapy
|
WO2017055522A1
(fr)
|
2015-09-29 |
2017-04-06 |
Academisch Medisch Centrum |
Protéines env stabilisées du vih
|
US11253717B2
(en)
|
2015-10-29 |
2022-02-22 |
Btl Healthcare Technologies A.S. |
Aesthetic method of biological structure treatment by magnetic field
|
JP7123800B2
(ja)
|
2016-02-05 |
2022-08-23 |
イノビオ ファーマシューティカルズ,インコーポレイティド |
がんのワクチン及びそれを用いた処置の方法
|
IL296595A
(en)
|
2016-03-28 |
2022-11-01 |
Ichor Medical Systems Inc |
Method and device for administering medical substances
|
US10538786B2
(en)
|
2016-04-13 |
2020-01-21 |
Janssen Pharmaceuticals, Inc. |
Recombinant arterivirus replicon systems and uses thereof
|
US11247039B2
(en)
|
2016-05-03 |
2022-02-15 |
Btl Healthcare Technologies A.S. |
Device including RF source of energy and vacuum system
|
US11464993B2
(en)
|
2016-05-03 |
2022-10-11 |
Btl Healthcare Technologies A.S. |
Device including RF source of energy and vacuum system
|
US11534619B2
(en)
|
2016-05-10 |
2022-12-27 |
Btl Medical Solutions A.S. |
Aesthetic method of biological structure treatment by magnetic field
|
US10583287B2
(en)
|
2016-05-23 |
2020-03-10 |
Btl Medical Technologies S.R.O. |
Systems and methods for tissue treatment
|
US10556122B1
(en)
|
2016-07-01 |
2020-02-11 |
Btl Medical Technologies S.R.O. |
Aesthetic method of biological structure treatment by magnetic field
|
KR20190082226A
(ko)
|
2016-10-17 |
2019-07-09 |
신테틱 제노믹스, 인코포레이티드. |
재조합 바이러스 레플리콘 시스템 및 그의 용도
|
BR112019011661A2
(pt)
|
2016-12-05 |
2020-01-07 |
Synthetic Genomics, Inc. |
Composições e métodos para aumentar expressão de gene
|
US11344618B2
(en)
|
2017-08-26 |
2022-05-31 |
Academisch Medisch Centrum |
HIV envelope glycoprotein immunogens
|
EP3723812A4
(fr)
|
2017-12-13 |
2022-02-16 |
Inovio Pharmaceuticals, Inc. |
Vaccins anticancer ciblant muc16 et leurs utilisations
|
EP3737397B1
(fr)
|
2017-12-13 |
2022-11-30 |
Inovio Pharmaceuticals, Inc. |
Vaccins anticancéreux ciblant l'antigène exprimé de façon préférentielle dans le mélanome (prame) et ses utilisations
|
KR102637862B1
(ko)
|
2017-12-13 |
2024-02-19 |
이노비오 파마수티컬즈, 인크. |
메소텔린을 표적으로 하는 암 백신 및 이의 용도
|
EA202091517A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и устройство для доставки вакцин против вируса гепатита b (hbv)
|
CA3086327A1
(fr)
|
2017-12-19 |
2019-06-27 |
Janssen Sciences Ireland Unlimited Company |
Vaccins contre le virus de l'hepatite b (vhb) et utilisations associees
|
US11020476B2
(en)
|
2017-12-19 |
2021-06-01 |
Janssen Sciences Ireland Unlimited Company |
Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)
|
US11021692B2
(en)
|
2017-12-19 |
2021-06-01 |
Janssen Sciences Ireland Unlimited Company |
Hepatitis B virus (HBV) vaccines and uses thereof
|
KR20200100745A
(ko)
|
2017-12-19 |
2020-08-26 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
B형 간염 바이러스(hbv)에 대한 면역 반응 유도를 위한 방법 및 조성물
|
WO2019143949A2
(fr)
|
2018-01-19 |
2019-07-25 |
Synthetic Genomics, Inc. |
Induction et amélioration des réponses immunitaires à l'aide de systèmes de réplicon de recombinaison
|
CA3116569C
(fr)
|
2019-04-11 |
2023-08-15 |
Btl Medical Technologies S.R.O. |
Procedes et dispositifs de traitement esthetique de structures biologiques par radiofrequence et energie magnetique
|
WO2020255035A1
(fr)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combinaison de vaccins contre le virus de l'hépatite b (vhb) et de dérivés de pyrimidine
|
TWI772823B
(zh)
|
2019-06-18 |
2022-08-01 |
愛爾蘭商健生科學愛爾蘭無限公司 |
B型肝炎病毒(hbv)疫苗與蛋白殼組裝調節劑之組合
|
EP3986915A1
(fr)
|
2019-06-18 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Company |
Construction de l'interleukine 12 recombinante et ses utilisations
|
WO2020254876A1
(fr)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Administration de particules de type viral de vaccins contre le virus de l'hépatite b (vhb)
|
JP2022536945A
(ja)
|
2019-06-18 |
2022-08-22 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
B型肝炎ウイルス(HBV)ワクチンおよびHBVを標的化するRNAiの組合せ
|
WO2020255038A1
(fr)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Association de vaccins contre le virus de l'hépatite b (vhb) et de dérivés de pyridopyrimidine
|
WO2020255022A1
(fr)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combinaison de vaccins contre le virus de l'hépatite b (vhb) et de dérivés d'aminopyridine en tant qu'inhibiteurs de hpk1
|
CA3140702A1
(fr)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combinaison de vaccins contre le virus de l'hepatite b (vhb) et de derives de dihydropyrimidine en tant que modulateurs d'assemblage de capside
|
AU2020296372A1
(en)
|
2019-06-18 |
2022-02-17 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis B virus (HBV) vaccines and anti-PD-1 antibody
|
WO2020255016A1
(fr)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combinaison de vaccins contre le virus de l'hépatite b (vhb) et de dérivés de dihydropyrimidine en tant que modulateurs de l'assemblage des capsides
|
WO2020255042A1
(fr)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combinaison de vaccins contre le virus de l'hépatite b (vhb) et d'un dérivé de pyrimidine
|
WO2020255011A1
(fr)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combinaison de vaccins contre le virus de l'hépatite b (vhb) et d'anticorps anti-pd-1 ou anti-pd-l1
|
CA3140588A1
(fr)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combinaison de vaccins contre le virus de l'hepatite b (vhb) et d'inhibiteur de pdl1 ou pd1 a petite molecule
|
WO2020255010A1
(fr)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combinaison d'une construction d'interleukine 12 recombinante et de vaccins contre le virus de l'hépatite b (vhb)
|
CA3140707A1
(fr)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Association de vaccins contre le virus de l'hepatite b (vhb) et de derives de quinazoline
|
WO2020255020A1
(fr)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Association de vaccins contre le virus de l'hépatite b (vhb) et d'inhibiteurs de pd-l1
|
CA3141238A1
(fr)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Vaccins contre le virus de l'hepatite b (vhb) et utilisations associees
|
AU2020297008A1
(en)
|
2019-06-18 |
2022-02-17 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis B virus (HBV) vaccines and HBV-targeting RNAi
|
WO2020255013A1
(fr)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combinaison de vaccins contre le virus de l'hépatite b (vhb) et de modulateurs d'assemblage de capside qui sont des dérivés d'amide
|
CA3140690A1
(fr)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combinaison de vaccins contre le virus de l'hepatite b (vhb) et de derives de dihydropyrimidine en tant que modulateurs d'assemblage de capside
|
WO2020255019A1
(fr)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combinaison de vaccins contre le virus de l'hépatite b (vhb) et d'un dérivé de la quinazoline
|
US20220305118A1
(en)
|
2019-06-20 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Carbohydrate nanocarrier delivery of hepatitis b virus (hbv) vaccines
|
AU2020295807A1
(en)
|
2019-06-20 |
2022-02-17 |
Janssen Sciences Ireland Unlimited Company |
Lipid nanoparticle or liposome delivery of hepatitis B virus (HBV) vaccines
|
CA3173876A1
(fr)
|
2020-05-04 |
2021-11-11 |
Tomas SCHWARZ |
Dispositif et methode pour traitement automatise d'un patient
|
US11878167B2
(en)
|
2020-05-04 |
2024-01-23 |
Btl Healthcare Technologies A.S. |
Device and method for unattended treatment of a patient
|
CA3181680A1
(fr)
|
2020-06-12 |
2021-12-16 |
University Of Rochester |
Codage et expression d'arnt ace
|
CA3188801A1
(fr)
|
2020-07-08 |
2022-01-13 |
Janssen Sciences Ireland Unlimited Company |
Vaccins a base de replicon d'arn contre le vhb
|
TW202245809A
(zh)
|
2020-12-18 |
2022-12-01 |
美商詹森藥物公司 |
用於治療b型肝炎病毒感染之組合療法
|
EP4267740A1
(fr)
|
2020-12-28 |
2023-11-01 |
Arcturus Therapeutics, Inc. |
Nucléases effectrices de type activateur de transcription (talens) ciblant le vhb
|
US11896816B2
(en)
|
2021-11-03 |
2024-02-13 |
Btl Healthcare Technologies A.S. |
Device and method for unattended treatment of a patient
|
WO2023150753A1
(fr)
|
2022-02-07 |
2023-08-10 |
University Of Rochester |
Séquences optimisées pour une expression d'adn améliorée et/ou une suppression de mutation non sens
|
WO2023233290A1
(fr)
|
2022-05-31 |
2023-12-07 |
Janssen Sciences Ireland Unlimited Company |
Agents d'arni ciblant pd-l1
|